Effect of drugs in secondary disease progression in patients with multiple sclerosis.

@article{Kappos2004EffectOD,
  title={Effect of drugs in secondary disease progression in patients with multiple sclerosis.},
  author={Ludwig Kappos},
  journal={Multiple sclerosis},
  year={2004},
  volume={10 Suppl 1},
  pages={S46-54; discussion S54-5}
}
Secondary progressive multiple sclerosis (SPMS) is a form of MS characterized by continuously worsening disability with or without superimposed relapses that occurs after a variable period of relapsing remitting disease and results in limited ambulation for almost all patients. The use of interferon beta (IFN beta) for immunomodulation in patients with SPMS has been evaluated in four recent clinical trials: The European multicentre trial on IFN beta-1b in SPMS (EUSPMS), the Secondary… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…